NAB2-STAT6は単一繊維性腫瘍におけるEGR1依存神経内分泌プログラムを駆動する
Connor Hill1,2, Alexandra Indeglia1,3, Francis Picone1
1The Wistar Institute, Philadelphia, United States.
eLife
|August 28, 2025
まとめ
単離性繊維性腫瘍 (SFT) は,遺伝子発現を変化させることで腫瘍の成長を促すNAB2-STAT6遺伝子の融合を伴う. この発見は悪性SFTの新たな治療目標を示しています
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 単離性繊維性腫瘍 (SFT) は,しばしば軟組織肉腫として誤診される希少なメゼンキマ性腫瘍である.
- 悪性SFTの再発率は高く,治療の選択肢は限られている.
- SFTの病原性の分子基盤はほとんど不明である.
研究 の 目的:
- SFTの開発を推進する分子メカニズムを解明する.
- 特徴的なNAB2-STAT6遺伝子融合の機能を特定する.
- SFTの潜在的治療標的を明らかにする.
主な方法:
- SFTのプライマリサンプルの分析
- SFTのための誘導可能なセルモデルの開発.
- NAB2-STAT6融合タンパク質の転写活性に関する研究.
- タンパク質の局所化と標的遺伝子発現の評価
主要な成果:
- NAB2- STAT6は,主にEGR1- 調節された遺伝子を標的とした転写共同活性化剤として作用する.
- 核融合タンパク質はNAB2,NAB1,EGR1の核局所化を促進する.
- STAT6分子は核転移と強化された共活性化に不可欠です.
- NAB2- STAT6は,SFTにおける神経内分泌遺伝子シグネチャーを上調する.
結論:
- NAB2-STAT6融合タンパク質は,SFTの病原性の主要な原動力である.
- NAB2-STAT6は 腫瘍の成長を促すための 細胞機構をハイジャックします
- このメカニズムを理解することで SFT 治療の新たな方法が生まれます
さらに関連する動画
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.1K
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
713
関連する概念動画
The Nucleolus
9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
